Delayed
Singapore S.E.
03:50:51 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
0.775
SGD
|
-1.90%
|
|
-3.12%
|
+9.93%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
685.5
|
1,645
|
1,038
|
911.5
|
1,045
|
1,171
|
-
|
-
|
Enterprise Value (EV)
1 |
646.7
|
1,436
|
519.6
|
589.9
|
1,045
|
837.9
|
784.1
|
1,171
|
P/E ratio
|
15.9
x
|
7.78
x
|
2.27
x
|
9.58
x
|
16.8
x
|
15.7
x
|
13.9
x
|
13.5
x
|
Yield
|
2.64%
|
5.3%
|
17.4%
|
-
|
-
|
4.35%
|
4.56%
|
5.51%
|
Capitalization / Revenue
|
2.09
x
|
2.75
x
|
1.05
x
|
2.39
x
|
4.05
x
|
3.79
x
|
3.34
x
|
3.39
x
|
EV / Revenue
|
1.98
x
|
2.4
x
|
0.52
x
|
1.55
x
|
4.05
x
|
2.71
x
|
2.24
x
|
3.39
x
|
EV / EBITDA
|
9.66
x
|
4.91
x
|
0.84
x
|
4.06
x
|
10.9
x
|
7.29
x
|
6.22
x
|
8.97
x
|
EV / FCF
|
20.8
x
|
7.28
x
|
1.14
x
|
-
|
-
|
16
x
|
11
x
|
16.1
x
|
FCF Yield
|
4.81%
|
13.7%
|
87.4%
|
-
|
-
|
6.24%
|
9.09%
|
6.2%
|
Price to Book
|
2.63
x
|
2.98
x
|
1.38
x
|
1.63
x
|
-
|
2.31
x
|
2.09
x
|
2.12
x
|
Nbr of stocks (in thousands)
|
1,482,168
|
1,482,168
|
1,482,168
|
1,482,168
|
1,482,168
|
1,482,168
|
-
|
-
|
Reference price
2 |
0.4625
|
1.110
|
0.7000
|
0.6150
|
0.7050
|
0.7900
|
0.7900
|
0.7900
|
Announcement Date
|
2/25/20
|
2/25/21
|
2/22/22
|
2/23/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
327.2
|
598
|
992.3
|
381.2
|
258.3
|
309.2
|
350.8
|
345.3
|
EBITDA
1 |
66.93
|
292.2
|
616.3
|
145.2
|
95.94
|
114.9
|
126.1
|
130.5
|
EBIT
1 |
51.06
|
273.5
|
598.4
|
126.2
|
78.88
|
96.95
|
107.4
|
111.1
|
Operating Margin
|
15.6%
|
45.74%
|
60.3%
|
33.11%
|
30.54%
|
31.35%
|
30.62%
|
32.18%
|
Earnings before Tax (EBT)
1 |
52.09
|
274.9
|
598.3
|
126.2
|
78.87
|
99.08
|
109.3
|
112.5
|
Net income
1 |
43.15
|
211.5
|
456.5
|
95.15
|
62.22
|
75.8
|
83.72
|
85.98
|
Net margin
|
13.19%
|
35.37%
|
46%
|
24.96%
|
24.09%
|
24.51%
|
23.87%
|
24.9%
|
EPS
2 |
0.0291
|
0.1427
|
0.3080
|
0.0642
|
0.0420
|
0.0504
|
0.0568
|
0.0585
|
Free Cash Flow
1 |
31.11
|
197.2
|
454.3
|
-
|
-
|
52.32
|
71.25
|
72.55
|
FCF margin
|
9.51%
|
32.98%
|
45.78%
|
-
|
-
|
16.92%
|
20.31%
|
21.01%
|
FCF Conversion (EBITDA)
|
46.48%
|
67.49%
|
73.71%
|
-
|
-
|
45.52%
|
56.49%
|
55.6%
|
FCF Conversion (Net income)
|
72.09%
|
93.25%
|
99.53%
|
-
|
-
|
69.03%
|
85.1%
|
84.38%
|
Dividend per Share
2 |
0.0122
|
0.0588
|
0.1221
|
-
|
-
|
0.0343
|
0.0360
|
0.0435
|
Announcement Date
|
2/25/20
|
2/25/21
|
2/22/22
|
2/23/23
|
2/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
38.8
|
209
|
518
|
322
|
-
|
333
|
387
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
31.1
|
197
|
454
|
-
|
-
|
52.3
|
71.3
|
72.6
|
ROE (net income / shareholders' equity)
|
17.4%
|
60.3%
|
76.8%
|
15%
|
-
|
15.6%
|
16.2%
|
17.4%
|
ROA (Net income/ Total Assets)
|
14.4%
|
49.4%
|
64.6%
|
13.3%
|
-
|
13.8%
|
23.4%
|
16%
|
Assets
1 |
298.7
|
428.2
|
706.2
|
714.2
|
-
|
551.3
|
357.3
|
539.1
|
Book Value Per Share
2 |
0.1800
|
0.3700
|
0.5100
|
0.3800
|
-
|
0.3400
|
0.3800
|
0.3700
|
Cash Flow per Share
|
0.0400
|
0.1500
|
0.3400
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
24.3
|
30
|
50.3
|
-
|
-
|
34
|
27.4
|
32.5
|
Capex / Sales
|
7.43%
|
5.02%
|
5.06%
|
-
|
-
|
10.99%
|
7.8%
|
9.41%
|
Announcement Date
|
2/25/20
|
2/25/21
|
2/22/22
|
2/23/23
|
2/28/24
|
-
|
-
|
-
|
Last Close Price
0.79
SGD Average target price
0.8275
SGD Spread / Average Target +4.75% Consensus |
1st Jan change
|
Capi.
|
---|
| +9.93% | 862M | | +10.41% | 27.12B | | -30.75% | 3.07B | | -15.97% | 2.52B | | +18.11% | 2.47B | | +3.70% | 2B | | -9.47% | 1.91B | | -2.22% | 1.47B | | +2.24% | 1.33B | | +18.92% | 1.19B |
Medical Supplies
|